(Q39361121)

11 September 2017

Survival plots of time-to-event outcomes in clinical trials: good practice and pitfalls (English)

1 reference

11 September 2017

3

Douglas G Altman

1 reference

11 September 2017

Stuart J Pocock

1

1 reference

PubMed ID

12020548

11 September 2017

Tim C Clayton

series ordinal

2

1 reference

PubMed ID

12020548

11 September 2017

language of work or name

English

0 references

publication date

1 May 2002

1 reference

11 September 2017

1 reference

11 September 2017

359

1 reference

11 September 2017

1686-1689

1 reference

11 September 2017

9318

1 reference

Nonparametric Estimation from Incomplete Observations

11 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908594-X

7 January 2021

Review of survival analyses published in cancer journals

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908594-X

7 January 2021

Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial--the Losartan Heart Failure Survival Study ELITE II.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908594-X

7 January 2021

Comparison of losartan and captopril in ELITE II

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908594-X

7 January 2021

Effects of pravastatin in 3260 patients with unstable angina: results from the LIPID study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908594-X

7 January 2021

Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908594-X

7 January 2021

Calculating the number needed to treat for trials where the outcome is time to an event

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908594-X

7 January 2021

Implications of trial results: the potentially misleading notions of number needed to treat and average duration of life gained

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908594-X

7 January 2021

Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908594-X

7 January 2021

Assessing treatment-time interaction in clinical trials with time to event data: a meta-analysis of hypertension trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908594-X

7 January 2021

10.1016/S0140-6736(02)08594-X

Identifiers

DOI

1 reference

11 September 2017

1 reference

PubMed ID

12020548